Daniel Fereidouni
A dedicated professional with over 9 years in the biotech and pharmaceutical industries, specializing in Analytical Method Qualification,... | Bedford, Massachusetts, United States
*50 free lookup(s) per month.
No credit card required.
Daniel Fereidouni’s Emails d.****@un****.com
Daniel Fereidouni’s Phone Numbers No phone number available.
Social Media
Daniel Fereidouni’s Location Bedford, Massachusetts, United States
Daniel Fereidouni’s Expertise A dedicated professional with over 9 years in the biotech and pharmaceutical industries, specializing in Analytical Method Qualification, Validation, and Transfer studies. Known for authoring protocols, supporting regulatory filings, and leading QC teams to ensure rigorous compliance and operational excellence. In the past few years, I had privilege to be part of the BLA filing and approval of Hemgenix (one of the first gene-therapy drugs). Additionally, I have contributed heavily to prepare AMT-191 (gene therapy candidate for Fabry disease) for IND and AMT-130 (candidate for Huntington disease) for Regenerative Medicine Advanced Therapy (RMAT) approval with FDA.
Daniel Fereidouni’s Current Industry Uniqure
Daniel
Fereidouni’s Prior Industry
University Of Missouri Department Of Plant Sciences
|
Monsanto
|
Noble Research Institute
|
Pfizer
|
Eurofins
|
Elanco
|
Uniqure
Not the Daniel Fereidouni you were looking for?
Find accurate emails & phone numbers for over 700M professionals.
Work Experience
Uniqure
Scientist-Analytical Method Validation
Fri Apr 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Elanco
QC senior specialist, Biochemist
Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri Apr 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Eurofins
Scientist II
Tue Aug 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Pfizer
Scientist
Wed Jun 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat Jul 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Noble Research Institute
Research Associate
Fri May 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri Apr 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Monsanto
Research Biologist I
Thu May 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri May 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
University Of Missouri Department Of Plant Sciences
Graduate Reseach Assistant
Thu Jul 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu May 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)Skills
Languages
Daniel Fereidouni Email Addresses
FAQ About Daniel Fereidouni
-
Daniel Fereidouni is located at
Bedford, Massachusetts, United States -
Daniel Fereidouni is a
A dedicated professional with over 9 years in the biotech and pharmaceutical industries, specializing in Analytical Method Qualification, Validation, and Transfer studies. Known for authoring protocols, supporting regulatory filings, and leading QC teams to ensure rigorous compliance and operational excellence. In the past few years, I had privilege to be part of the BLA filing and approval of Hemgenix (one of the first gene-therapy drugs). Additionally, I have contributed heavily to prepare AMT-191 (gene therapy candidate for Fabry disease) for IND and AMT-130 (candidate for Huntington disease) for Regenerative Medicine Advanced Therapy (RMAT) approval with FDA. Uniqure -
Daniel Fereidouni currently works in the
Uniqure -
Daniel Fereidouni specializes in
A dedicated professional with over 9 years in the biotech and pharmaceutical industries, specializing in Analytical Method Qualification, Validation, and Transfer studies. Known for authoring protocols, supporting regulatory filings, and leading QC teams to ensure rigorous compliance and operational excellence. In the past few years, I had privilege to be part of the BLA filing and approval of Hemgenix (one of the first gene-therapy drugs). Additionally, I have contributed heavily to prepare AMT-191 (gene therapy candidate for Fabry disease) for IND and AMT-130 (candidate for Huntington disease) for Regenerative Medicine Advanced Therapy (RMAT) approval with FDA. -
Daniel Fereidouni speaks the following languages:
No languages available. -
Daniel Fereidouni has prior experience in the following industries:
Elanco , Eurofins , Pfizer , Noble Research Institute , Monsanto , University Of Missouri Department Of Plant Sciences -
Daniel Fereidouni has the following professional experience:
Uniqure , Elanco , Eurofins , Pfizer , Noble Research Institute , Monsanto , University Of Missouri Department Of Plant Sciences . -
You can view Daniel Fereidouni’s
LinkedIn profile at LinkedIn URL. -
Daniel Fereidouni’s work email addresses are
[email protected] . -
Daniel Fereidouni works at
Uniqure
People you may be interested in
- Annika Harper
- Tatiana Macêdo
- Michael Waits Sr
- Beverly Swanson
- Russell Yasuhara
- Eddie Crabtree
- Anvar Gafiatullin
- Rozenn Le Godec
Chief Marketing Officer
Técnico de Segurança do Trabalho na Recuperadora Sales Gama
Pastor at First Baptist Church Crandall
Corp Secretary for Escom Properties
Business Line Controller at Infineon Technologies, LLC
PRODUCTION SUPERVISOR at Cosma International Group of Magna International
Director, Consulting Solutions, at PricewaterhouseCoopers
Chef de groupe ŠKODA chez CARIVIERA (Volkswagen, Audi, Seat, Cupra, Skoda et Volkswagen Utilitaires)